Get started
Author

Kevin Christian Montecillo Gulay

Observed names: GULAY, Kevin Christian Montecillo, Gulay, Kevin C. M., Kevin C. Gulay, Kevin C. M. Gulay, Kevin Christian Gulay, Kevin Christian M. Gulay, Kevin Christian Montecillo GULAY, Kevin Christian Montecillo Gulay (16991114), Kevin Christian Montecillo. Gulay, Kevin Gulay, Kevin Gulay Gulay
ORCID: 0000-0002-9568-3590
Observed ORCID: 0000-0002-9568-3590
OpenAlex ID: A5041073957
Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma
2023 · Kevin Christian Montecillo Gulay, Xinlian Zhang, et al. · Cancer Research · 86
PDF
KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma
2020 · Kevin Christian Montecillo Gulay, Keisuke Aoshima, et al. · Journal of genetics and genomics/Journal of Genetics and Genomics · 20
Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages
2022 · Kevin Christian M. Gulay, Keisuke Aoshima, et al. · Scientific Reports · 18
PDF
Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression
2021 · Yamato Sajiki, Satoru Konnai, et al. · Scientific Reports · 17
PDF
Cellular atypia is negatively correlated with immunohistochemical reactivity of CD31 and vWF expression levels in canine hemangiosarcoma
2017 · Aprilia MAHARANI, Keisuke AOSHIMA, et al. · Journal of Veterinary Medical Science · 16
PDF
Experimental models of pancreas cancer: what has been the impact for precision medicine?
2025 · Vasiliki Pantazopoulou, Casie S. Kubota, et al. · Journal of Clinical Investigation · 11
PDF
MICAL2 Promotes Pancreatic Cancer Growth and Metastasis
2025 · Bharti Garg, Sohini Khan, et al. · Cancer Research · 10
PDF
Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells
2018 · Keisuke Aoshima, Yuki Fukui, et al. · BMC Veterinary Research · 9
PDF
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC
2025 · Nathan L. Tran, Jiewei Jiang, et al. · Nature Chemical Biology · 8
High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines
2019 · Atsuya Morita, Keisuke Aoshima, et al. · Research in Veterinary Science · 7
PDF
MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis
2024 · Bharti Garg, Bharti Garg, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
2024 · Nathan L. Tran, Jiewei Jiang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
2022 · Jonathan Weitz, Kevin Christian Montecillo Gulay, et al. · Journal of Visualized Experiments · 3
PDF
Abstract A072: Strategies to improve KRAS G12D inhibitor (MRTX1133) therapy in pancreatic ductal adenocarcinoma
2022 · Kevin Christian M. Gulay, Edgar Esparza, et al. · Cancer Research · 3
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression
2021 · Kevin Christian M. Gulay, Keisuke Aoshima, et al. · Veterinary and Comparative Oncology · 3
PDF
Redirecting cytomegalovirus immunity against pancreas cancer for immunotherapy
2026 · Remi Marrocco, Jay Patel, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Abstract B096: Acquired resistance to KRAS inhibition modulates the pancreatic cancer tumor microenvironment
2024 · Kevin Christian Montecillo Gulay, Jay Patel, et al. · Cancer Research · 1
Supplementary Data from Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma
2023 · Kevin Christian Montecillo Gulay, Xinlian Zhang, et al. · 1
Peliosis Hepatis with Chylous Ascites in a Dog
2021 · Kevin Christian Montecillo Gulay, Noriyuki Nagata, et al. · Journal of Comparative Pathology · 1
PDF
Abstract A054: MICAL2 promotes oncogenic Kras -induced pancreatic cancer initiation by regulating RAC1-mediated acinar to ductal metaplasia
2026 · Nirakar Rajbhandari, Deepa Sheik . Pran Babu, et al. · Cancer Research
Abstract B093: Cytomegalovirus immunotherapy: A mutation agnostic approach for pancreatic cancer treatment
2026 · Philip Salu, Catarina Maia, et al. · Cancer Research
Abstract B137: Targeting MICAL2 sensitizes pancreatic cancer cells to gemcitabine and enhances therapeutic response
2026 · Ponmathi Panneerpandian, Kevin Christian Montecillo. Gulay, et al. · Cancer Research
Abstract B054: Combined RAS Inhibition and Immune Checkpoint Blockade Overcome NF-κB-Mediated Immune Evasion in Chemoresistant Pancreatic Cancer
2026 · Kevin Christian Gulay, Alexei Martsinkovskiy, et al. · Cancer Research
Abstract B014: Leveraging dynamic epigenetic landscapes to decode tumor-associated macrophages in pancreatic ductal adenocarcinoma
2026 · Debbie K. Ledezma, Kevin Gulay, et al. · Cancer Research
Abstract B006: Actin Cytoskeleton Dynamics in Tumor Cells Orchestrate Stromal Desmoplasia and Immune Evasion in Pancreatic Cancer
2026 · Bharti Garg, Evangeline Sari. Mose, et al. · Cancer Research
Works count: 72
Citation count: 221
H-index: 8
I10-index: 7
Year
Topic
Type